• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
CVB
Click for more information
0.00% 17.5¢

CURVEBEAM AI LIMITED - Charts / Financials

Market Cap $38.25M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare Medical Devices

Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam... Curvebeam AI Ltd is engaged in the research, design, and manufacturing of cone beam computed tomography (CT) imaging systems for the orthopedic specialties. The Company is engaged in providing point-of-care diagnostic cone beam CT imaging solutions with artificial intelligence (AI) and deep learning AI (DLAI). Its product categories include orthopedics and bone health. Its orthopedics products include HiRise, LineUP, pedCAT Premium, pedCAT, InReach, and CubeVue Software. Its bone health products include InReach HR-pQCT, and OSSView. HiRise is a bilateral, weight bearing CT imaging of the entire lower extremities including hips/pelvis, distal upper extremities. LineUP is a bilateral, weight bearing CT imaging of the distal lower extremities and distal upper extremities. InReach HR-pQCT is a high resolution peripheral quantitative CT (HR-pQCT) imaging system designed for the point-of-care. OssView Bone Fragility software analyzes HR-pQCT images to measure the bone microarchitecture.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 10.07am 04/06/2024 (20 minute delay) ?
Day
Open 17.5¢   Day High 17.5¢   Day Low 17.5¢
Daily Volume 6571
Bids   Sellers
Number Price Volume   Number Price Volume
2 17.0¢ 26376   2 18.0¢ 18441

Directors & Senior Management

Mr. Greg Brown Chief Executive Officer, Managing Director, Director
Mr. Ura Auckland Chief Financial Officer, Company Secretary
Mr. Arun Singh Chief Operating Officer, Chief Technology Officer - CT, President, US Division, Director
Mr. S. Turner Dean Chief Sales Officer
Mr. Ego Seeman Medical Director – Endocrinology
Mr. Robert Lilley Non-Executive Chairman of the Board
Mr. Hashan De Silva Non-Executive Director
Mr. Kate Robb Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
17.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $38.25M
Open High Low Value Volume
17.5¢ 17.5¢ 17.5¢ $1.15K 6.571K

Buyers (Bids)

No. Vol. Price($)
2 26376 17.0¢
 

Sellers (Offers)

Price($) Vol. No.
18.0¢ 18441 2
View Market Depth
Last trade - 13.18pm 04/06/2024 (20 minute delay) ?
Last
17.5¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
17.5¢ 17.5¢ 17.5¢ 1500
Last updated 10.07am 04/06/2024 ?

Top Stories

AFT reaches US distribution milestone for Maxigesic Rapid tablets

AFT Pharmaceuticals Ltd has announced a distribution deal with American wholesaler Alexso in relation to its Maxigesic Rapid tablets.
Immutep targets $100m for lung cancer drug trial tests Immutep has launched a capital raise aiming to boost its war chest by $100 million to progress late stage trials for lung cancer sufferers.
Daily ASX Market Open: Commodity prices to weigh | June 4, 2024 The pricing of key commodities will matter this morning – as both iron ore and oil were tipped to fall on overseas markets - and that’s set to weigh on the ASX200. Futures suggests the index will tip just slightly into the red (0.13%).
Daily Market ASX Update: Waning profits suppress index | June 4, 2024 The ASX200 responded well to the latest corporate profits data from the ABS, but not enough to push the market into the green.In March, Australia’s gross corporate profits fell -2.5%, far below analyst estimates of just -0.9% for the month.This fresh evidence of a cooling economy ...
Drilling doubles gold-copper mineralisation zone at GEO-01 for Antipa Antipa Minerals Ltd has announced it has doubled the mineralisation zone of its GEO-01 target in Western Australia through drilling.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.